Prospective, longitudinal observational study of individuals with MEHMO syndrome or eIF2-related conditions to identify clinical, imaging, and fluid markers that can be used to further diagnosis, monitoring, or evaluating efficacy of candidate therapies (https://clinicaltrials.gov/study/NCT06019182).
EIF2S3